Fibrinogen beta-chain -C148T polymorphism is associated with increased fibrinogen, C-reactive protein, and interleukin-6 in patients undergoing coronary artery bypass grafting

Inflammation

Volumn 35, Issue 2, 2012, Pages 429-435

  Wypasek, Ewa ^a,b   Stepien, Ewa ^a,b   Kot, Malgorzata ^a   Plicner, Dariusz ^a,b   Kapelak, Boguslaw ^a,b   Sadowski, Jerzy ^a,b   Undas, Anetta ^a,b  

^a JAGIELLONIAN UNIVERSITY MEDICAL COLLEGE   (Poland)

^b Krakowski Szpital Specjalistyczny Im Jana Pawła II   (Poland)

Author keywords

C148T FGB polymorphism; CABG; CRP; Fibrinogen; IL 6; Inflammation

Indexed keywords

C REACTIVE PROTEIN; DNA; FIBRINOGEN; INTERLEUKIN 6;

ADULT; AGED; ALLELE; ARTICLE; CONTROLLED STUDY; CORONARY ARTERY BYPASS GRAFT; CORONARY ARTERY OBSTRUCTION; DEATH; DNA EXTRACTION; FEMALE; FIBRINOGEN BETA CHAIN GENE; GENE; GENETIC POLYMORPHISM; GENOTYPE; HEART INFARCTION; HETEROZYGOTE; HUMAN; INTENSIVE CARE; MAJOR CLINICAL STUDY; MALE; POSTOPERATIVE PERIOD; PREOPERATIVE PERIOD; PROTEIN BLOOD LEVEL; RESTRICTION FRAGMENT LENGTH POLYMORPHISM; STROKE;

ADULT; AGED; AGED, 80 AND OVER; ALLELES; BIOLOGICAL MARKERS; C-REACTIVE PROTEIN; CORONARY ARTERY BYPASS; FEMALE; FIBRINOGEN; HUMANS; INFLAMMATION; INTERLEUKIN-6; MALE; MIDDLE AGED; POLYMORPHISM, RESTRICTION FRAGMENT LENGTH; POLYMORPHISM, SINGLE NUCLEOTIDE; TREATMENT OUTCOME;

EID: 84863777607     PISSN: 03603997     EISSN: 15732576     Source Type: Journal    
DOI: 10.1007/s10753-011-9332-6     Document Type: Article

References (34)

1. Kant, J.A., A.J. Fornace Jr., D. Saxe, M.I. Simon, O.W. McBride, and G.R. Crabtree. 1985. Evolution and organization of the fibrinogen locus on chromosome 4:Gene duplication accompanied by transposition and inversion. Proceedings of the National Academy of Sciences of the United States of America 82: 2344-2348. (Pubitemid 15064484)
2. Roy, S.N., G. Mukhopadhyay, and C.M. Redman. 1990. Regulation of fibrinogen assembly. Transfection of Hep G2 cells with B beta cDNA specifically enhances synthesis of the three component chains of fibrinogen. The Journal of Biological Chemistry 265: 6389-6393.
3. Thomas, A., H. Lamlum, S. Humphries, and F. Green. 1994. Linkage disequilibrium across the fibrinogen locus as shown by five genetic polymorphisms, G/A-455 (Hae III), C/T-148(Hind III/Alu I), T/G11689(Ava II), and Bcl I (b-fibrinogen) and Taq I (a-fibrinogen) and their detection by PCR. Human Mutation 3: 79-81.
4. Cook, D.G., F.P. Cappuccio, R.W. Atkinson, P.D. Wicks, A. Chitolie, E.R. Nakandakare, G.A. Sagnella, and S.E. Humphries. 2001. Ethnic differences in fibrinogen levels: the role of environmental factors and the beta-fibrinogen gene. American Journal of Epidemiology 153: 799-806. (Pubitemid 32319709)
5. Papageorgiou, N., D. Tousoulis, G. Siasos, and C. Stefanadis. 2010. Is fibrinogen a marker of inflammation in coronary artery disease? Hellenic Journal of Cardiology 51: 1-9.
6. van 't Hooft, F.M., S.J. von Bahr, A. Silveira, A. Iliadou, P. Eriksson, and A. Hamsten. 1999. Two common, functional polymorphisms in the promoter region of the beta-fibrinogen gene contribute to regulation of plasma fibrinogen concentration. Arteriosclerosis, Thrombosis, and Vascular Biology 12: 3063-3070. (Pubitemid 30029837)
7. Tybjaerg-Hansen, A., B. Agerholm-Larsen, S.E. Humphries, S. Abildgaard, P. Schnohr, and B.G. Nordestgaard. 1997. A common mutation (G-455-A) in the beta-fibrinogen promoter is an independent predictor of plasma fibrinogen, but not of ischemic heart disease. A study of 9,127 individuals based on the Copenhagen City Heart Study. The Journal of Clinical Investigation 99: 3034-3039. (Pubitemid 27278681)
8. Mosesson, M.W., K.R. Siebenlist, and D.A. Meh. 2001. The structure and biological features of fibrinogen and fibrin. Annals of the New York Academy of Sciences 936: 11-30. (Pubitemid 32613890)
9. Rost, N.S., P.A. Wolf, C.S. Kase, M. Kelly-Hayes, H. Silbershatz, J. M. Massaro, R.B. D'Agostino, C. Franzblau, and P.W. Wilson. 2001. Plasma concentration of C-reactive protein and risk of ischemic stroke and transient ischemic attack: the Framingham study. Stroke 32: 2575-2579. (Pubitemid 33055308)
10. Mitchell, J.D., H.P. Grocott, B. Phillips-Bute, J.P. Mathew, M.F. Newman, and S. Bar-Yosef. 2007. Cytokine secretion after cardiac surgery and its relationship to postoperative fever. Cytokine 38: 37-42. (Pubitemid 46990923)
11. Brull, D.J., N. Serrano, F. Zito, L. Jones, H.E. Montgomery, A. Rumley, P. Sharma, G.D. Lowe, M.J. World, S.E. Humphries, and A.D. Hingorani. 2003. Human CRP gene polymorphism influences CRP levels: implications for the prediction and pathogenesis of coronary heart disease. Arteriosclerosis, Thrombosis, and Vascular Biology 23: 2063-2069. (Pubitemid 37433201)
12. Cotton, J.M., K.E. Webb, A. Mathur, J.F. Martin, and S.E. Humphries. 2000. Impact of the -455G>A promoter polymorphism in the B fibrinogen gene on stimulated fibrinogen production following bypass surgery. Thrombosis and Haemostasis 84: 926-927.
13. Balciunas, M., L. Bagdonaite, R. Samalavicius, L. Griskevicius, and A. Vuylsteke. 2009. Pre-operative high sensitive C-reactive protein predicts cardiovascular events after coronary artery bypass grafting surgery: a prospective observational study. Annals of Cardiac Anaesthesia 12: 127-132.
14. Gaudino, M., F. Andreotti, R. Zamparelli, A. Di Castelnuovo, G. Nasso, F. Burzotta, L. Iacoviello, M.B. Donati, R. Schiavello, A. Maseri, and G. Possati. 2003. The 2174G/C interleukin-6 polymorphism influences postoperative interleukin-6 levels and post-operative atrial fibrillation. Is atrial fibrillation an inflammatory complication? Circulation 108: 195-199.
15. Wypasek, E., A. Undas, M. Sniezek-Maciejewska, B. Kapelak, D. Plicner, E. Stepien, and J. Sadowski. 2010. The increased plasma C-reactive protein and interleukin-6 levels in patients undergoing coronary artery bypass grafting surgery are associated with the interleukin-6-174G>C gene polymorphism. Annals of Clinical Biochemistry 47: 343-349.
16. Puyo, C.A., S.M. Tricomi, and T.E. Dahms. 2008. Early biochemical markers of inflammation in a swine model of endotracheal intubation. Anesthesiology 109: 88-94.
17. Yende, S., M. Quasney, Q. Zhang, K. Frederick, L. Kessler, and R. G. Wunderink. 2002. Impact of cytokine gene polymorphisms on outcomes of coronary artery bypass graft surgery. Chest 121: 86S. (Pubitemid 34248368)
18. Hatano, S. 1976. Experience from a multicentre stroke register: a preliminary report. Bulletin of the World Health Organization 54: 541-553. (Pubitemid 8114220)
19. Eagle, K.A., R.A. Guyton, R. Davidoff, F.H. Edwards, G.A. Ewy, T.J. Gardner, J.C. Hart, H.C. Herrmann, L.D. Hillis, A.M. Jr Hutter, B.W. Lytle, R.A. Marlow, W.C. Nugent, T.A. Orszulak, and for the American College of Cardiology/American Heart Association Task Force on Practice Guidelines Committee to Update the 1999 Guidelines for Coronary Artery Bypass Graft Surgery, American Society for Thoracic Surgery, and Society of Thoracic Surgeons. 2004. ACC/AHA 2004 guideline update for coronary artery bypass graft surgery: summary article: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines. Journal of the American College of Cardiology 44(1146-54): e213-e310.
20. Clauss, A. 1957. Gerinnungsphysiologische Schnellmethode zur Bestimmung des Fibrinogens. [Rapid physiological coagulation method in determination of fibrinogen.]. Acta Haematologica 17: 237-246.
21. Blake, G.J., C. Schmitz, K. Lindpaintner, and P.M. Ridker. 2001. Mutation in the promoter region of the beta-fibrinogen gene and the risk of future myocardial infarction, stroke and venous thrombosis. European Heart Journal 22: 2262-2266. (Pubitemid 34000981)
22. Steuer, J., L.G. Hörte, B. Lindahl, and E. Ståhle. 2002. Impact of perioperative myocardial injury on early and long-term outcome after coronary artery bypass grafting. European Heart Journal 23: 1219-1227. (Pubitemid 35215248)
23. Carrier, M., M. Pellerin, L.P. Perrault, B.C. Solymoss, and L.C. Pelletier. 2000. Troponin levels in patients with myocardial infarction after coronary artery bypass grafting. The Annals of Thoracic Surgery 69: 435-440. (Pubitemid 30127872)
24. Force, T., P. Hibberd, G. Weeks, A.J. Kemper, P. Bloomfield, D. Tow, M. Josa, S. Khuri, and A.F. Parisi. 1990. Perioperative myocardial infarction after coronary artery bypass surgery. Clinical significance and approach to risk stratification. Circulation 82: 903-912. (Pubitemid 20316742)
25. Chaitman, B.R., E.L. Alderman, L.T. Sheffield, T. Tong, L. Fisher, M.B. Mock, R.D. Weins, G.C. Kaiser, D. Roitman, R. Berger, B. Gersh, H. Schaff, M.G. Bourassa, and T. Killip. 1983. Use of survival analysis to determine the clinical significance of new Q waves after coronary bypass surgery. Circulation 67: 302-307.
26. Palmerini, T., A. Marzocchi, C. Marrozzini, L.B. Reggiani, C. Savini, G. Marinelli, R. Di Bartolomeo, and A. Branzi. 2007. Preoperative C-reactive protein levels predict 9-month mortality after coronary artery bypass grafting surgery for the treatment of left main coronary artery stenosis. European Journal of Cardiothoracic Surgery 31: 685-690. (Pubitemid 46400486)
27. Biancari, F., J. Lahtinen, S. Lepojärvi, P. Rainio, E. Salmela, R. Pokela, M. Lepojärvi, J. Satta, and T.S. Juvonen. 2003. Preoperative C-reactive protein and outcome after coronary artery bypass surgery. The Annals of Thoracic Surgery 76: 2007-2012. (Pubitemid 37510524)
28. Milazzo, D., L.M. Biasucci, N. Luciani, L. Martinelli, C. Canosa, R. Schiavello, A. Maseri, and G. Possati. 1999. Elevated levels of C-reactive protein before coronary artery bypass grafting predict recurrence of ischemic events. The American Journal of Cardiology 84: 459-461. (Pubitemid 29398669)
29. Grocott, H.P., W.D. White, R.W. Morris, M.V. Podgoreanu, J.P. Mathew, D.M. Nielsen, D.A. Schwinn, and M.F. Newman. 2005. Perioperative Genetics and Safety Outcomes Study (PEGASUS) Investigative Team. Genetic polymorphisms and the risk of stroke after cardiac surgery. Stroke 36: 1854-1858.
30. Selim, M. 2007. Perioperative stroke. The New England Journal of Medicine 356: 706-713.
31. Asimakopoulos, G. 2001. Systemic inflammation and cardiac surgery: an update. Perfusion 16: 353-360. (Pubitemid 32834429)
32. Ascione, R., C.T. Lloyd, M.J. Underwood, A.A. Lotto, A.A. Pitsis, and G.D. Angelini. 2000. Inflammatory response after coronary revascularization with or without cardiopulmonary bypass. The Annals of Thoracic Surgery 69: 1198-1204. (Pubitemid 30259386)
33. Verschuur, M., M. de Jong, L. Felida, M.P. de Maat, and H.L. Vos. 2005. A hepatocyte nuclear factor-3 site in the fibrinogen beta promoter is important for interleukin 6-induced expression, and its activity is influenced by the adjacent -148C/T polymorphism. The Journal of Biological Chemistry 280: 16763-16771. (Pubitemid 41389134)
34. Gardemann, A., O. Schwartz, W. Haberbosch, N. Katz, T. Weiss, H. Tillmanns, F.W. Hehrlein, W. Waas, and A. Eberbach. 1997. Positive association of the beta fibrinogen H1/H2 gene variation to basal fibrinogen levels and to the increase in fibrinogen concentration during acute phase reaction but not to coronary artery disease and myocardial infarction. Thrombosis and Haemostasis 77: 1120-1126. (Pubitemid 27311980)